Objective: To explore the value of intensive acid suppression in elderly patients with acute non-variceal upper gastrointestinal hemorrhage (ANVUGIB) treated by endoscopic hemostasis. Methods: 106 elderly patients with ANVUGIB admitted from March 2016 to March 2018 were randomly divided into a control group of 53 patients and an observation group of 53 patients, who all underwent endoscopic hemostasis treatment. The control group combined with conventional acid suppression program, the observation group combined with enhanced acid suppression program. The clinical effects of the two groups, treatment related indicators, serum urea nitrogen (BUN), hematocrit after treatment, 72 h after treatment (Hct) level changes and prognosis outcomes were observed. Results: The total effective rate of the observation group was 98.11%, which was statistically significant compared with the control group 84.91% (P<0.05).The hemostasis time, the time of hematemesis, the time of disappearance of melena and the length of hospital stay in the observation group were significantly shorter than those in the control group. The blood transfusion volume was significantly less than that of the control group, and the difference was statistically significant (P<0.05).There was no significant difference in serum BUN and Hct levels between the two groups before treatment (P>0.05).After 72 hours of treatment, the serum BUN and Hct levels in the observation group were compared with the control group (P<0.05).The incidence of adverse reactions in the observation group was 13.21%, and the mortality was 1.89%. Compared with the control group of 9.43% and 7.55%, the difference was not statistically significant (P>0.05).The rebleeding rate of the observation group was 1.89%, which was significantly higher than that of the control group 13.21% (P<0.05). Conclusion: The enhanced acid suppression program is applied to the elderly ANVUGIB for endoscopic hemostasis. The effect is significant, the rate of rebleeding is low, and the serum BUN and Hct levels can be significantly adjusted, and the safety is high, thus it is worthy of promotion. |
[1] 曾莉蓉,陈鹏飞,魏文斌,等.急性非静脉曲张性上消化道出血治疗中内镜止血的应用价值[J].现代消化及介入诊疗,2016,21(1):137-139.
[2] 卜玲玲,吴菁.内镜下治疗急性非静脉曲张性上消化道出血的临床效果[J].检验医学与临床,2016,13(24):3512-3514.
[3] 中华内科杂志社,中华医学杂志社,中华消化杂志社,等.急性非静脉曲张性上消化道出血诊治指南(2015年,南昌)[J].中华消化杂志,2015,35(12):793-798.
[4] 中国医师协会急诊医师分会.急性上消化道出血急诊诊治流程专家共识[J].中国急救医学,2015,35(10):865-873.
[5] 柏愚,李兆申.急性非静脉曲张性上消化道出血诊治-老问题,新观念,新指南,新解读[J].胃肠病学,2017,22(8):449-451.
[6] 闻静,邵明,孙娟,等,老年人急性非静脉曲张性上消化道出血病因及相关因素分析[J].蚌埠医学院学报,2013,38(7):806-808.
[7] PEZZULO G, KRUGER D. Assessing upper gastrointestinal bleeding in adults[J].JAAPA, 2014, 27(9):19-25.
[8] 王薇,付肖岩.急性非静脉曲张性上消化道出血老年患者的临床特点分析[J].国际消化病杂志,2014,34(5):358-360.
[9] 陈晓露,宋瑛,徐俊荣,等.急性非静脉曲张性上消化道出血内镜下治疗的临床分析[J].现代消化及介入诊疗,2015,20(3):257-259.
[10] 刘北京,宋建华,王丽双,等.泮托拉唑持续泵入用于非静脉曲张性上消化道出血止血效果观察[J].山东医药,2014,54(26):105.
[11] KORKMAZ U, ALCELIK A, EROGLUM,et al.Pantoprazole-induced thrombocytopenia in a patient with upper gastrointestinal bleeding[J].Blood Coagul Fibrinolysis,2013,24(3):352-353.
[12] 陈正彦,刘君颖,张然,等.强化抑酸方案对行内镜止血术的老年ANVUGIB患者手术相关临床指标、再出血率及实验室指标的影响[J].中国内镜杂志,2018,24(3):41-45.
[13] 郝婷婷,温彦丽,戴光荣,等.血清尿素氮水平与上消化道出血关系的研究[J].现代检验医学杂志,2017,32(3):86-88.
[14] 邱伟伟,陈建荣.急性上消化道出血病程中尿素氮变化的临床分析[J].中国医刊,2015,50(8):84-86.
[15] 陈菲,徐小勇,王永平,等.血尿素氮对呼吸危重症患者预后评估的价值[J].东南大学学报(医学版),2017,36(2):253-256.
[16] 郑光威,林振吕,梁文福,等.红细胞压积对急性上消化道出血患者行内镜检查的安全性及预后的影响[J].中国急救医学,2015,35(9):811-814,815. |